Director & President and CEO
Director & President and CEO at MADRIGAL PHARMACEUTICALS, INC., filing insider transactions between 2026-07-20 and 2026-09-11.
| SEC ↗ |
| 2026-09-11 | MDGL | Sale | 106 | $534.06 | $57K | SEC ↗ |
| 2026-09-11 | MDGL | Sale | 1,202 | $542.60 | $652K | SEC ↗ |
| 2026-09-11 | MDGL | Sale | 120 | $546.38 | $66K | SEC ↗ |
| 2026-09-11 | MDGL | Sale | 761 | $544.83 | $415K | SEC ↗ |
| 2026-09-11 | MDGL | Sale | 687 | $540.59 | $371K | SEC ↗ |
| 2026-09-11 | MDGL | Sale | 60 | $533.09 | $32K | SEC ↗ |
| 2026-09-11 | MDGL | Sale | 368 | $541.64 | $199K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 520 | $538.30 | $280K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 522 | $530.23 | $277K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 640 | $537.17 | $344K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 644 | $535.27 | $345K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 396 | $534.20 | $212K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 1,040 | $536.11 | $558K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 131 | $527.88 | $69K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 160 | $542.55 | $87K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 215 | $539.03 | $116K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 347 | $529.27 | $184K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 362 | $541.65 | $196K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 368 | $531.99 | $196K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 505 | $540.19 | $273K | SEC ↗ |
| 2026-09-09 | MDGL | Sale | 512 | $533.09 | $273K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 1 | $550.72 | $551 | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 680 | $547.70 | $372K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 545 | $544.71 | $297K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 47 | $548.87 | $26K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 280 | $555.05 | $155K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 275 | $545.71 | $150K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 269 | $547.08 | $147K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 153 | $550.01 | $84K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 140 | $542.75 | $76K | SEC ↗ |
| 2026-07-20 | MDGL | Sale | 110 | $543.79 | $60K | SEC ↗ |